Ocular syphilis: opportunities to address important unanswered questions.
Ocular syphilis: opportunities to address important unanswered questions.
复制标题
眼梅毒:解决重要未解答问题的机会。
DOI:
10.1136/sextrans-2016-052570
复制
发表时间:
2016
影响因子:
3.6
通讯作者:
Ghanem,KhalilG
中科院分区:
文献类型:
--
作者:
Tuddenham,Susan;Ghanem,KhalilG
The US Centers for Disease Control and Prevention (CDC) issued a clinical advisory late last year on ocular syphilis. Between December 2014 and March 2015, 12 cases of ocular syphilis were reported from two US cities, San Francisco and Seattle. 1 Subsequent case finding identified more than 200 cases reported over the last 2 years from 20 states. Whether this is the result of one or more oculotropic strains (neuroinvasive strains have been described) 2 or enhanced case detection due to, for example, the increasing use of the reverse sequence algorithm for syphilis screening, is unclear. In Maryland, to date, following the release of the advisory, 13 cases have been identified through careful record reviews with 9 (70%) of the 13 presenting as late ocular syphilis (personal communication Elisabeth Liebow and Alexandra Goode, Maryland Department of Health and Mental Hygiene). If this increasing case detection is the result of a circulating strain, the strain has been circulating for a while. Irrespective of the cause of this observed increase in the number of cases of ocular syphilis, there are several important yet unanswered clinical questions: what is the relationship between ocular and neurosyphilis? How does HIV impact ocular syphilis and this relationship? Is a lumbar puncture (LP) necessary for the evaluation of patients suspected of having ocular syphilis? What is the best treatment of ocular syphilis? Other issues to clarify include the relationship of ocular syphilis presentation to stage of syphilis infection, the risk of ocular syphilis in serofast patients, and whether ocular syphilis in patients with a previous record of treatment represents recrudescence or reinfection. Several studies have tried to address one or more of these questions. All of these studies suffered from a small sample size that limited their power to draw meaningful conclusions. In this issue, Tsuboi et al have published a case series drawn from a retrospective chart review of patients attending an HIV clinical centre. They examine the clinical course and prognosis of ocular syphilis in 20 HIV-infected Japanese men. The patients were followed for an average of 21 months after their diagnosis. The paper highlights the need for prompt recognition and treatment of the syndrome, as having ocular symptoms for> 28 days before treatment was associated with poor prognosis. Of the 17 patients who had an LP performed, 53% were diagnosed with neurosyphilis based on a positive serum serology and one or more abnormalities on cerebrospinal fluid (CSF) examination. This is a timely paper, given the recent CDC clinical advisory, however, it is still a retrospective review with a relatively small sample size, and includes only HIV-positive patients. As such, important questions still remain (Tsuboi et al, in this issue). Ocular syphilis may occur during any stage of infection and may involve almost any portion of the eye. Save for preretinal opacities and acute posterior placoid chorioretinitis, 3 two ocular manifestations that have been reported to be specific for syphilis, most clinical manifestations of ocular syphilis are non-specific. Thus, most diagnoses of ocular syphilis tend to be presumptive based on ocular signs and symptoms and positive syphilis serologies. Involvement of most of the eye structures can occur at different stages of syphilis, though Spoor et al make a distinction between acute ocular inflammation (presenting as anterior and posterior uveitis, optic neuritis or perineuritis) being more commonly associated with early syphilis, and optic atrophy and pupillary abnormalities as well as chorioretinitis being associated with late syphilis. 4 5 However, a systematic characterisation of …